Pharma giant Bayer China partners with VeChain

Renowned pharmaceutical firm Bayer China has collaborated with blockchain firm VeChain.
The partnership aims to design a blockchain-based platform that increases clinical trial traceability in drugs.
The platform, CSecure, will be underpinned by blockchain-as-a-service (BaaS)-based tool - ToolChain.

Rajarshi Mitra Independent Analyst

Bayer China, one of the largest pharmaceutical companies in the world, has partnered with blockchain firm VeChain. The partnership aims to design a blockchain-based platform that increases clinical trial traceability in drugs.

The platform, dubbed Csecure, will assign a unique batch number to all the clinical trial drugs entering the blockchain. Through features such as identification codes and time stamps, stakeholders on the blockchain can monitor the drug’s movement along the supply chain in real-time. CSecure will be underpinned by blockchain-as-a-service (BaaS)-based tool - ToolChain. This will allow VeChain to design and build full-fledged distributed ledger technology solutions that meet all clients' requirements.

VeChain CEO and co-founder Sunny Lu said:

We’ve experienced the rigorousness of the medical industry by working with Bayer China. I feel Bayer’s professionalism and superb work ethic towards medicine and healthcare causes as a whole.

Author

Rajarshi Mitra

Independent Analyst

Rajarshi entered the blockchain space in 2016. He is a blockchain researcher who has worked for Blockgeeks and has done research work for several ICOs. He gets regularly invited to give talks on the blockchain technology and cryptocurrencies.

XRP extends recovery as on-chain activity grows

Ripple (XRP) ticks up and trades around $1.13 at the time of writing on Tuesday. This rebound aligns with a broader recovery in the cryptocurrency market, attributed to reports that mediators between the United States (US) and Iran are seeking a 10-day cessation of strikes to find a way back to the signed Memorandum of Understanding (MoU).

Ethereum Price Forecast: ETH continues July uptrend with 20% rise after triggering buy signal

Ethereum (ETH) has gained 3% on Tuesday, extending its July gains above 20% after key on-chain indicators highlighted a resumption of buying activity. The strong performance so far in July comes a few days after ETH triggered the Market Value to Realized Value (MVRV) Buy signal. ETH has been up by roughly 22% since the signal.

Chainlink becomes top 20 best performer, 3 reasons behind the move

Chainlink (LINK) has become the best-performing asset in the top 20 this week, leading every other major cryptocurrency. The cryptocurrency jumped 10.18% to $8.71, its highest level since early June. Three major factors explain the double-digit rise over the past week.

Crypto Today: Bitcoin, Ethereum, XRP extend rebound amid returning institutional capital inflows

Cryptocurrency prices extend a broad recovery, led by Bitcoin (BTC), trading above $66,000 at the time of writing on Tuesday. Ethereum (ETH) remains bullish above $1,940, after logging four straight days of gains. Meanwhile, Ripple (XRP) hovers around $1.13, building on the reclaimed $1.10 critical level.

Bitcoin’s potential recovery in the second half hinges on these 4 catalysts

Bitcoin (BTC) has fallen over 34% in the first half of this year as the King Crypto failed to capitalize on a good semester for risk assets despite the woes from the Iran war.